Product
Part 2 ES002023
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
An Open-Label, Multicenter, First-in-Human, Dose-Escalation, Phase 1 Study of ES002023 in Patients With Locally Advanced or Metastatic Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2023-12-01